Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
13.60
+0.05 (0.37%)
At close: May 22, 2026, 4:00 PM EDT
13.62
+0.02 (0.14%)
After-hours: May 22, 2026, 7:00 PM EDT
Dr. Reddy's Laboratories Employees
Dr. Reddy's Laboratories had 27,811 employees as of March 31, 2025. The number of employees increased by 763 or 2.82% compared to the previous year.
Employees
27,811
Change (1Y)
763
Growth (1Y)
2.82%
Revenue / Employee
$128,821
Profits / Employee
$16,432
Market Cap
11.65B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 27,811 | 763 | 2.82% |
| Mar 31, 2024 | 27,048 | 1,185 | 4.58% |
| Mar 31, 2023 | 25,863 | 1,068 | 4.31% |
| Mar 31, 2022 | 24,795 | 2,056 | 9.04% |
| Mar 31, 2021 | 22,739 | 1,089 | 5.03% |
| Mar 31, 2020 | 21,650 | -316 | -1.44% |
| Mar 31, 2019 | 21,966 | -1,558 | -6.62% |
| Mar 31, 2018 | 23,524 | 853 | 3.76% |
| Mar 31, 2017 | 22,671 | 496 | 2.24% |
| Mar 31, 2016 | 22,175 | 1,802 | 8.85% |
| Mar 31, 2015 | 20,373 | 1,952 | 10.60% |
| Mar 31, 2014 | 18,421 | 1,804 | 10.86% |
| Mar 31, 2013 | 16,617 | 1,417 | 9.32% |
| Mar 31, 2012 | 15,200 | 277 | 1.86% |
| Mar 31, 2011 | 14,923 | 1,468 | 10.91% |
| Mar 31, 2010 | 13,455 | 2,227 | 19.83% |
| Mar 31, 2009 | 11,228 | 1,653 | 17.26% |
| Mar 31, 2008 | 9,575 | 555 | 6.15% |
| Mar 31, 2007 | 9,020 | 1,495 | 19.87% |
| Mar 31, 2006 | 7,525 | 1,390 | 22.66% |
| Mar 31, 2005 | 6,135 | -20 | -0.32% |
| Mar 31, 2004 | 6,155 | 303 | 5.18% |
| Mar 31, 2003 | 5,852 | 409 | 7.51% |
| Mar 31, 2002 | 5,443 | 314 | 6.12% |
| Mar 31, 2001 | 5,129 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Viatris | 30,000 |
| Elanco Animal Health | 9,900 |
| Amneal Pharmaceuticals | 8,700 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| Neurocrine Biosciences | 2,000 |
| United Therapeutics | 1,400 |
| Lantheus Holdings | 1,193 |
RDY News
- 5 days ago - Dr Reddy’s rolls out oral semaglutide in India - The Times of India
- 8 days ago - Dr. Reddy's (RDY) Introduces Generic Semaglutide Injection in Canada - GuruFocus
- 8 days ago - Dr. Reddy’s launches generic Semaglutide injection in Canada - TheFly
- 9 days ago - Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada - Business Wire
- 10 days ago - Dr. Reddy's Laboratories launches generic Semaglutide Injection in Canada - Business Upturn
- 10 days ago - Pharma Stocks Today, May 15: Dr. Reddy’s Lab rises 1.32%, Lupin gains 1.19%, Strides Pharma falls 2.35% - Business Upturn
- 11 days ago - Dr. Reddy's Laboratories Q4 Earnings Call Highlights - MarketBeat
- 11 days ago - Dr Reddy's, Dixon Technology & more: Top stocks to watch today - The Times of India